Upgrade to SI Premium - Free Trial

UBS Reiterates Buy Rating on CVS Health (CVS)

March 25, 2026 9:14 AM
UBS analyst Kevin Caliendo reiterated a Buy rating and $97.00 price target on CVS Health (NYSE: CVS).The analyst commmented, "On ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments